155 related articles for article (PubMed ID: 30864860)
21. Dietary Supplements for Erectile Dysfunction: Analysis of Marketed Products, Systematic Review, Meta-Analysis and Rational Use.
Petre GC; Francini-Pesenti F; Vitagliano A; Grande G; Ferlin A; Garolla A
Nutrients; 2023 Aug; 15(17):. PubMed ID: 37686709
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy of Korean red ginseng for erectile dysfunction.
Choi HK; Seong DH; Rha KH
Int J Impot Res; 1995 Sep; 7(3):181-6. PubMed ID: 8750052
[TBL] [Abstract][Full Text] [Related]
23. [Erectile dysfunction - treatment with substances of natural origin].
Stasiak M; Żarłok K; Tomaszewski W
Wiad Lek; 2016; 69(3 pt 2):576-581. PubMed ID: 28478429
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of PDE5 inhibitors alone or in combination with alpha-blockers for the treatment of erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and meta-analysis.
Yan H; Zong H; Cui Y; Li N; Zhang Y
J Sex Med; 2014 Jun; 11(6):1539-45. PubMed ID: 24621088
[TBL] [Abstract][Full Text] [Related]
25. Oral L-citrulline supplementation improves erectile function in rats with acute arteriogenic erectile dysfunction.
Shiota A; Hotta Y; Kataoka T; Morita M; Maeda Y; Kimura K
J Sex Med; 2013 Oct; 10(10):2423-9. PubMed ID: 23844604
[TBL] [Abstract][Full Text] [Related]
26. The prevalence of erectile dysfunction among Brazilian men screened for prostate cancer.
Paranhos M; Antunes A; Andrade E; Freire G; Srougi M
BJU Int; 2009 Oct; 104(8):1130-3. PubMed ID: 19426190
[TBL] [Abstract][Full Text] [Related]
27. Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia?
Roumeguère T; Zouaoui Boudjeltia K; Hauzeur C; Schulman C; Vanhaeverbeek M; Wespes E
BJU Int; 2009 Aug; 104(4):511-7. PubMed ID: 19239452
[TBL] [Abstract][Full Text] [Related]
28. [TREATMENT OPTIMIZATION IN PATIENTS WITH ERECTILE DYSFUNCTION].
Pushkar DJ; Kolontarev KB
Urologiia; 2015; (4):90-2, 94-5. PubMed ID: 26665773
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US.
Goldstein I; Kim E; Steers WD; Pryor JL; Wilde DW; Natanegara F; Wong DG; Ahuja S
J Sex Med; 2007 Jan; 4(1):166-175. PubMed ID: 17233782
[TBL] [Abstract][Full Text] [Related]
30. Improvement of erectile function by a combination of French maritime pine bark and roburins with aminoacids.
Stanislavov R; Rohdewald P
Minerva Urol Nefrol; 2015 Mar; 67(1):27-32. PubMed ID: 25664962
[TBL] [Abstract][Full Text] [Related]
31. The self-estimation index of erectile function-no sexual intercourse (SIEF-NS): a multidimensional scale to assess erectile dysfunction in the absence of sexual intercourse.
Yuan Y; Zhang Z; Gao B; Peng J; Cui W; Song W; Xin Z; Guo Y
J Sex Med; 2014 May; 11(5):1201-7. PubMed ID: 24589237
[TBL] [Abstract][Full Text] [Related]
32. [Lower urinary tract symptoms and erectile dysfunction].
Lavalle LL; Almagro AA; Bravo CB; Martínez LC
Arch Esp Urol; 2010 Oct; 63(8):655-62. PubMed ID: 21045248
[TBL] [Abstract][Full Text] [Related]
33. A systematic review and evidence-based analysis of ingredients in popular male testosterone and erectile dysfunction supplements.
Kuchakulla M; Narasimman M; Soni Y; Leong JY; Patel P; Ramasamy R
Int J Impot Res; 2021 Apr; 33(3):311-317. PubMed ID: 32358510
[TBL] [Abstract][Full Text] [Related]
34. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
Ikuerowo SO; Akindiji YO; Akinoso OA; Akinlusi FM; Esho JO
Urol Int; 2008; 80(3):296-9. PubMed ID: 18480635
[TBL] [Abstract][Full Text] [Related]
35. The burden and extent of comorbid conditions in patients with erectile dysfunction.
Hackett G
Int J Clin Pract; 2009 Aug; 63(8):1205-13. PubMed ID: 19624788
[TBL] [Abstract][Full Text] [Related]
36. Medical treatments for benign prostatic hyperplasia and sexual function.
Giuliano F
BJU Int; 2008 Nov; 102 Suppl 2():8-12. PubMed ID: 19032604
[No Abstract] [Full Text] [Related]
37. Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot Study.
Yiou R; Hamidou L; Birebent B; Bitari D; Lecorvoisier P; Contremoulins I; Khodari M; Rodriguez AM; Augustin D; Roudot-Thoraval F; de la Taille A; Rouard H
Eur Urol; 2016 Jun; 69(6):988-91. PubMed ID: 26439886
[TBL] [Abstract][Full Text] [Related]
38. Editorial comment.
de la Rosette JJ
Urology; 2010 Jun; 75(6):1458. PubMed ID: 20513508
[No Abstract] [Full Text] [Related]
39. Propionyl-L-carnitine, L-arginine and niacin in sexual medicine: a nutraceutical approach to erectile dysfunction.
Gianfrilli D; Lauretta R; Di Dato C; Graziadio C; Pozza C; De Larichaudy J; Giannetta E; Isidori AM; Lenzi A
Andrologia; 2012 May; 44 Suppl 1():600-4. PubMed ID: 21966881
[TBL] [Abstract][Full Text] [Related]
40. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
